Brigalk2 Study: A Multicentric Real-World Study Evaluating Brigatinib In Alk Positive Advanced Pre-Treated Non-Small Cell Lung Cancers: Long-Term Follow-Up With Focus On Lorlatinib Efficacy After Brigatinib
ANNALS OF ONCOLOGY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要